Management of neuronopathic Gaucher disease: a European consensus.
about
Review and evaluation of the methodological quality of the existing guidelines and recommendations for inherited neurometabolic disordersImiglucerase and its use for the treatment of Gaucher's diseaseSystemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher diseasePreviously unrecognized behavioral phenotype in Gaucher disease type 3Neurogenic bladder dysfunction presenting as urinary retention in neuronopathic Gaucher diseaseGaucher disease and its treatment options.Type 2 Gaucher disease: phenotypic variation and genotypic heterogeneity.Gaucher disease: pathological mechanisms and modern management.Skeletal aspects of Gaucher disease: a review.Biochemistry of glycosphingolipid storage disorders: implications for therapeutic interventionGaucher Disease in Two Siblings.Clinical neurogenetics: neuropathic lysosomal storage disorders.Four-year follow-up of chronic neuronopathic Gaucher disease in Europeans using a modified severity scoring tool.Neuronopathic lysosomal storage diseases: clinical and pathologic findings.Hematopoietic Stem Cell Gene Therapy for Storage Disease: Current and New Indications.Evoked potentials and neurocognitive functions in pediatric Egyptian Gaucher patients on enzyme replacement therapy: a single center experience.Enzyme replacement therapy for Gaucher disease in Australia.Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms.GBA mutations in Gaucher type I Venezuelan patients: ethnic origins and frequencies.Study of multimodal evoked potentials in patients with type 1 Gaucher's disease.The importance of correct phenotyping in Gaucher disease.Cellular Uptake of Glucocerebrosidase in Gaucher Patients Receiving Enzyme Replacement Treatment.
P2860
Q26771677-5AA07543-35C0-4A0B-A698-E2745A517623Q28287175-57D063F5-CA3C-43FA-B595-167AA2CF5928Q28482370-7ED03E52-2038-402C-837D-38BB51A247B2Q30854636-83524F8D-8973-480F-A64F-45BE60532A66Q33414179-B0F92736-125F-44BC-8CC6-4277E38A7490Q34386658-F4726D4B-C2E3-4067-AC4B-CF54CE0BEE0BQ34479337-7133920B-7996-43EC-A00C-C573E2970798Q34556549-935A177B-B50A-4787-8A45-660FC546FCBAQ34661021-A9E29A93-AC72-462E-ADEC-395FF2F9AC99Q35153233-770C7320-9CCD-43BF-8360-D60F5EBBEB13Q37280284-AA871AA7-2E19-49A1-9319-D0177E62CFADQ37705073-ACEF6ADC-0694-42A4-9231-1BEA751AD836Q37882509-AE12BC5C-EA8E-4E53-A8B9-B76A34314113Q38116812-A1853B2C-E142-4548-85D4-93C0880FF8B6Q39227498-4485E64E-052B-4D56-B391-D8A096565A23Q39510850-88FDF7D7-5F32-468B-B569-295026164881Q40442149-7B0A2D6A-E39C-4614-B984-8CC7A974A57EQ44412880-8981836B-A8D2-4AE6-B6DA-78E9DE4A037EQ47923220-3F66F837-F38E-4672-838F-BF52A9BD8A40Q48952782-0D895601-ECD5-43DD-A114-FB483761F362Q50455919-9B13400D-6B23-4559-AF2B-BEBEECA3762FQ53121616-2A30D13C-9A7E-4163-8629-9AFBD77446B4
P2860
Management of neuronopathic Gaucher disease: a European consensus.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Management of neuronopathic Gaucher disease: a European consensus.
@ast
Management of neuronopathic Gaucher disease: a European consensus.
@en
Management of neuronopathic Gaucher disease: a European consensus.
@nl
type
label
Management of neuronopathic Gaucher disease: a European consensus.
@ast
Management of neuronopathic Gaucher disease: a European consensus.
@en
Management of neuronopathic Gaucher disease: a European consensus.
@nl
prefLabel
Management of neuronopathic Gaucher disease: a European consensus.
@ast
Management of neuronopathic Gaucher disease: a European consensus.
@en
Management of neuronopathic Gaucher disease: a European consensus.
@nl
P2093
P356
P1476
Management of neuronopathic Gaucher disease: a European consensus
@en
P2093
Neuronopathic Gaucher Disease Task Force of the European Working Group on Gaucher Disease
T B de Villemeur
T Collin-Histed
P2888
P304
P356
10.1023/A:1010514614570
P577
2001-06-01T00:00:00Z
P6179
1026887105